Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease.
View / Open Files
Authors
Ritchie, Craig W
Russ, Tom C
Banerjee, Sube
Barber, Bob
Boaden, Andrew
Fox, Nick C
Holmes, Clive
Isaacs, Jeremy D
Leroi, Ira
Lovestone, Simon
Norton, Matt
Pearson, Jim
Perry, Richard
Pickett, James
Waldman, Adam D
Wong, Wai Lup
Rossor, Martin N
Burns, Alistair
Publication Date
2018-07-30Journal Title
Alzheimers Res Ther
ISSN
1758-9193
Publisher
Springer Science and Business Media LLC
Type
Article
Metadata
Show full item recordCitation
Ritchie, C. W., Russ, T. C., Banerjee, S., Barber, B., Boaden, A., Fox, N. C., Holmes, C., et al. (2018). Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease.. Alzheimers Res Ther https://doi.org/10.1186/s13195-018-0372-0
Abstract
Since the publication of this article [1], it has come to the attention of the authors that information for one of the authors was not included in the competing interests section. Craig Richie has declared potential competing interests with the following companies; Janssen, Eisai, Pfizer, Eli Lilly, Roche Diagnostics, Boeringher Ingleheim, Novartis, AC Immune, Ixico, Aridhia, Amgen, Berry Consultants, Lundbeck, Sanofi, Quintiles (IQVIA) and Takeda. The full competing interests section for this article can be found below.
Keywords
1109 Neurosciences
Sponsorship
Medical Research Council (MR/L023784/2)
Medical Research Council (MR/L023784/1)
Identifiers
External DOI: https://doi.org/10.1186/s13195-018-0372-0
This record's URL: https://www.repository.cam.ac.uk/handle/1810/278555
Rights
All Rights Reserved
Rights Holder: The Author(s).
Licence URL: https://www.rioxx.net/licenses/all-rights-reserved/
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk